Ludwig San Diego Study Identifies Deadly Genetic Synergy in Cancer Cells and Shows it Might Be Exploited for Therapy

A Ludwig Cancer Research study has identified a new instance in which the simultaneous mutation of two nonessential genes—neither of which is on its own vital to cell survival—can cause cancer cell death.
27-Jul-2020 4:35 PM EDT Add to Favorites

Ludwig Cancer Research Study Finds Reprogramming of Immune Cells Enhances Effects of Radiotherapy in Preclinical Models of Brain Cancer

A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the...
15-Jul-2020 3:20 PM EDT Add to Favorites

Juanita L. Merchant Appointed to the Ludwig Institute’s Scientific Advisory Committee

Ludwig Cancer Research welcomes Juanita L. Merchant to the Scientific Advisory Committee of the Ludwig Institute for Cancer Research.
14-Jul-2020 9:00 AM EDT Add to Favorites

Epigenetics Researcher Yang Shi Appointed Member of Ludwig Oxford

It is with great pleasure that Ludwig Cancer Research announces the appointment of Yang Shi as Member of the Oxford Branch of the Ludwig Institute for Cancer Research.
1-Jul-2020 9:00 AM EDT Add to Favorites

Ludwig Lausanne Study Charts the Immune Landscape of Multiple Brain Cancers

A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast and skin.
28-May-2020 12:15 PM EDT Add to Favorites

Ludwig Oxford Director Xin Lu Elected to the Royal Society

Ludwig Cancer Research extends its congratulations to Xin Lu, director of the Oxford Branch of the Ludwig Institute for Cancer Research, on her election to the Fellowship of the Royal Society.
29-Apr-2020 11:25 AM EDT Add to Favorites

Ludwig MSK Study Reveals Bile Metabolite of Gut Microbes Boosts Immune Cells

A Ludwig Cancer Research study has discovered a novel means by which bacterial colonies in the small intestine support the generation of regulatory T cells—immune cells that suppress autoimmune reactions and inflammation.
15-Apr-2020 11:00 AM EDT Add to Favorites

Targeting Turncoat Immune Cells to Treat Cancer

A Ludwig Cancer Research study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the harsh microenvironment of the tumor.
17-Feb-2020 11:00 AM EST Add to Favorites

See All News